| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2001; 40: 988-994
© 2001 British Society for Rheumatology
Original Papers |
Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis
1 Rheumatology Unit, Prince of Wales Hospital,
2 Inflammation Research Unit, School of Pathology, University of New South Wales, Sydney, Australia,
3 Division of Clinical Immunology and Rheumatology, Academic Medical Centre, Amsterdam, The Netherlands and
4 The Combined Centre for the Rheumatic Diseases, Rachel Forster Hospital, Sydney, Australia
Objective. To compare macrophage infiltration and expression of chemokines and matrix metalloproteinases (MMPs) in synovial tissue between patients with early and long-standing rheumatoid arthritis (RA).
Methods. Knee synovial biopsies were taken from 22 patients with early (<1 yr) and 22 patients with long-standing (>5 yr) RA and immunostained with antibodies specific for CD68; macrophage inflammatory protein (MIP)-1
and monocyte chemoattractant protein (MCP)-1; MMP-1 and -3 and the tissue inhibitors of metalloproteinases (TIMP)-l and -2. Immunostaining was quantified using a colour video image analysis system.
Results. CD68+ macrophage infiltration and the expression of MIP-1
, MCP-1, MMP-1, MMP-3, TIMP-1, and TIMP-2 were observed in synovial tissue of patients with early RA. In long-standing RA, there was a further increase in CD68+ macrophage infiltration and MIP-1
expression in the synovial lining layer. CD68 expression correlated with MIP-1
(R=0.39, P=0.01), but not with MCP-1 expression.
Conclusion. Macrophage accumulation, and the expression of chemokines and MMPs in synovial tissue occur in early RA. Targeting chemokines which play a role in the migration of macrophages into the joints may be of therapeutic benefit in RA patients.
KEY WORDS: Rheumatoid arthritis, Chemokines, Matrix metalloproteinases, Tissue inhibitors of matrix metalloproteinases.
Correspondence to: P. P. Youssef, Inflammation Research Unit, School of Pathology, University of New South Wales, Sydney, 2052, Australia.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Hueber, B. H Tomooka, X. Zhao, B. A Kidd, J. W Drijfhout, J. F Fries, W. J van Venrooij, A. L Metzger, M. C Genovese, and W. H Robinson Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines Ann Rheum Dis, June 1, 2007; 66(6): 712 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Shiau, S.-Y. Chen, M.-Y. Chang, C.-H. Su, S.-Y. Chung, Y.-T. Yo, C.-R. Wang, and C.-L. Wu Prothymosin {alpha} Lacking the Nuclear Localization Signal as an Effective Gene Therapeutic Strategy in Collagen-Induced Arthritis J. Immunol., April 1, 2007; 178(7): 4688 - 4694. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pierer, J. Rethage, R. Seibl, R. Lauener, F. Brentano, U. Wagner, H. Hantzschel, B. A. Michel, R. E. Gay, S. Gay, et al. Chemokine Secretion of Rheumatoid Arthritis Synovial Fibroblasts Stimulated by Toll-Like Receptor 2 Ligands J. Immunol., January 15, 2004; 172(2): 1256 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hanyuda, T. Kasama, T. Isozaki, M. M. Matsunawa, N. Yajima, H. Miyaoka, H. Uchida, Y. Kameoka, H. Ide, and M. Adachi Activated leucocytes express and secrete macrophage inflammatory protein-1{alpha} upon interaction with synovial fibroblasts of rheumatoid arthritis via a {beta}2-integrin/ICAM-1 mechanism Rheumatology, November 1, 2003; 42(11): 1390 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Gladue, L. A. Tylaska, W. H. Brissette, P. D. Lira, J. C. Kath, C. S. Poss, M. F. Brown, T. J. Paradis, M. J. Conklyn, K. T. Ogborne, et al. CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases J. Biol. Chem., October 17, 2003; 278(42): 40473 - 40480. [Abstract] [Full Text] [PDF] |
||||
![]() |
J J Haringman, M C Kraan, T J M Smeets, K H Zwinderman, and P P Tak Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis Ann Rheum Dis, August 1, 2003; 62(8): 715 - 721. [Abstract] [Full Text] [PDF] |
||||



